Avita Medical is a medical device company that provides a unique approach to skin regeneration



The Company

Avita Medical is a medical device company that transforms lives through its unique and innovative skin regeneration solutions. We are a publicly listed, global medical technology company trading on the Australian Stock Exchange (ASX:AVH) and OTC Markets (OTCQX:AVMXY). We develop and distribute highly innovative regenerative products.

Our patented and proprietary collection and application technology provides innovative treatment solutions derived from a patient’s own skin to treat a wide range of wounds, scars and skin defects. Our devices create a Regenerative Epithelial Suspension (RES™) – an autologous suspension comprised of the cells and wound healing factors necessary to regenerate natural healthy skin.

Avita’s regenerative product portfolio includes ReCell® for burns aimed at plastic reconstructive procedures, ReGenerCell™ for chronic wounds and ReNovaCell™ for the restoration of pigmentation.

Read more



The Company

Avita Medical is a medical device company that transforms lives through its unique and innovative skin regeneration solutions. We are a publicly listed, global medical technology company trading on the Australian Stock Exchange (ASX:AVH) and OTC Markets (OTCQX:AVMXY). We develop and distribute highly innovative regenerative products.

Read more


6895

Procedures *

32

Market Approvals *

64

Published Papers *

47%

reduction in hospital stay20

38%

reduction in donor skin21

ReCell® is a medical device that enables medical professionals to collect cells from a small sample of a patient’s own skin to create a suspension that can regenerate wounds caused by burns.

55%

reduction in wound area in 4 weeks2

33%

pain reduction in one week7

ReGenerCell™ is a medical device that allows medical professionals to swiftly create a suspension of skin cells that can trigger healing in chronic wounds, such as venous leg ulcers and diabetic foot ulcers.

78%

re-pigmentation2

reduced

healing time, risk of infection and scarring4,6,7

ReNovaCell™ is a medical device that delivers a skin cell suspension for treating aesthetic applications: restoring pigmentation, and improving the appearance of scars, sun-damaged skin, wrinkles and lesions.

Twitter

follow

Tuesday, September 27th, 2016 at 5:04am
EBA Avita surgeons dinner with some of the great and the good from the global burns community. https://t.co/0m4GO6hv5Q AvitaMedical photo
Monday, September 26th, 2016 at 8:03pm
Poster also recommended that cell suspensions, such as those produced by ReCell, be used for patients presenting wi… https://t.co/7Edr0Z7yNg
Monday, September 26th, 2016 at 7:59pm
Poster: Use of cell suspensions for hypopigmentation - study concluded that ReCell provided comparable results to c… https://t.co/vESLjNWv2l
Monday, September 26th, 2016 at 6:52pm
ReCell featured in a series of posters. Take home messages to follow... #AVH #AVMXY #EBA https://t.co/UoiNkYMalV AvitaMedical photo

Facebook

follow

Avita Medical
Avita Medical at Hyatt Regency Miami.Thursday, September 1st, 2016 at 9:40am

Data presented at ISBI 2016, Miami on Meek Micrografting in paediatric burn patients by Dr Roux Martinez from the Red Cross War Memorial Children’s Hospital, Cape Town, South Africa, demonstrated that applying ReCell onto Meek sheets prior to application enhanced epithelialisation. #ISBI2016

2    View on Facebook
Avita Medical
Avita Medical added 2 new photos — at Hyatt Regency Miami.Wednesday, August 31st, 2016 at 3:07am

Interesting presentation at ISBI 2016, Miami by Prof. Fiona Wood on the impact of the timing of surgical intervention and operative surgical time on patient outcomes in burn wound repair. Key takeout - early intervention and ReCell leads to better outcomes. #isbi2016

1    View on Facebook

Share Price

Last Trade: 0.089 Last Trade: 1.42
High: 0.089 High: 1.42
Low: 0.089 Low: 1.402
Close: 0.089 Close: 1.45
Volume: 105,333 Volume: 1680
Prices are delayed by 20 minutes